|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 145.00 GBX | +0.35% |
|
+14.62% | +13.28% |
| 07-29 | Diaceutics PLC Reports Revenue Results for the Half Year Ended 30 June 2026 | CI |
| 06-02 | Diaceutics PLC, 2025 Earnings Call, May 26, 2026 |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | 2.98x | - | 2.45x | 11.18x | 35.8x | -.--% | 165M | |
| -105.65x | 9.6x | 0.3x | 21.63x | 54.65x | -87.41x | -.--% | 57.8B | |
| 31.74x | 3.36x | 0.45x | 2.36x | 20.36x | 34.53x | 1.5% | 3.46B | |
| 97.99x | 6.36x | 1.42x | 12.53x | 19.53x | 115.97x | 0.26% | 3.35B | |
| 36.07x | 13.4x | 2.14x | 11.74x | 25.09x | 28.98x | 1.96% | 2.1B | |
| -86.67x | 4.33x | 1.02x | - | - | - | 0.09% | 1.48B | |
| 27.05x | 2.19x | 3.58x | 3.6x | 14.57x | 18.95x | 0.66% | 1.25B | |
| 40.26x | 8.18x | 1.25x | 16.64x | 25.82x | 28.34x | 0.57% | 1.19B | |
| 14.42x | 4.25x | 0.36x | - | - | - | 0.4% | 1.07B | |
| -1.66x | - | 0.21x | 5.03x | 8.22x | 95.07x | -.--% | 450M | |
| 23.96x | 3.03x | 1.42x | 2.56x | 8.09x | 13.46x | - | 156M | |
| -44.44x | 4.62x | 0.51x | 1.52x | 11.05x | -45.18x | - | 126M | |
| Average | 3.01x | 5.66x | 1.15x | 8.01x | 19.86x | 23.85x | 0.54% | 6.05B | |
| Weighted average by Cap. | -77.66x | 8.89x | 0.50x | 19.31x | 48.60x | -62.53x | 0.17% |
- Stock Market
- Stocks
- DXRX Stock
- Sector Diaceutics PLC
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
